You are subscribed to the Managed Healthcare Executive eNews.

Managed Healthcare Executive eNews

Print Subscribe

Digital Edition Subscribe

March 15, 2013

Web Version  |  Digital Edition  |  Share with a colleague

Facebook Like   Twitter Tweet

Today's Headlines

How to define repeat imaging

Many health plans are applying utilization management tools to medical imaging benefits to reduce costs and cut unnecessary use. However, today's benchmarks on imaging are likely not specific enough. » More

ADVERTISEMENT

Don't just monitor diabetes… manage it!

ARKRAY offers managed care organizations unique solutions to lower PMPM costs; improve member outcomes; and covert members to GLUCOCARD® blood glucose meters. We want to help you improve your members' health. Read more

States divided by Medicaid

Medicaid expansion is driving a wedge between legislatures and governors, and increasingly between states and their citizens.
» More

ADVERTISEMENT

Download Case Study : Reduce Rx Costs and Improve Member Health

Denying high-priced Rx claims may contain costs in the short term, but this practice can lead to poor adherence and complications for patients. Download this case study to learn how health plans can reduce drug spend with more affordable medication alternatives and provider and member education.

NCPA: Regulations hike prices

As drug coverage increases as a result of expanded health insurance and Medicaid coverage under PPACA, unnecessary regulations will increase prescription drug costs, according to a study from the National Center for Policy Analysis (NCPA). » More

ADVERTISEMENT

Could you or your PBM be saving more on your drug spend? Find out more.

Click here to see how new drug price benchmark, Predictive Acquisition Cost (PAC), can be leveraged to support MAC optimization and reduce Rx costs. This proof of concept analysis identifies drug groups for which the current MAC needs evaluating in order to reach targeted drug prices and significantly reduce drug spend overall.

Monthly schizophrenia drug approved

FDA has approved aripiprazole (Abilify Maintena, Otsuka and Lundbeck) as an extended-release injectable drug for the treatment of schizophrenia. » More

ADVERTISEMENT

Healthcare solutions, every step of the way.

Walgreens Specialty Pharmacy provides a range of services through multiple channels. From therapy management to infusion to 24/7 clinical support, better care means better outcomes.
Learn more about Walgreens Specialty Pharmacy: click here.

 

Business Strategy

Payers struggle against market headwinds

Costs drive Medicaid's reality

Get the most out of care management

Obama backs cuts in Medicare drug payments

Drug manufacturers seek payer feedback

Keep in touch with MHE

We value your input. Please send your comments and article ideas to Editor in Chief Julie Miller. [email protected].

 
Powered by Modern Medicine Advanstar Medical Communications Group